JCB logo
Accuri Cytometers
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 439K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raoul, C.
Right arrow Articles by Pettmann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raoul, C.
Right arrow Articles by Pettmann, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/1999//1049 $5.00
The Journal of Cell Biology, Volume 147, Number 5, , 1999 1049-1062


Original Article

Programmed Cell Death of Embryonic Motoneurons Triggered through the FAS Death Receptor



Cédric Raoula, Christopher E. Hendersona, and Brigitte Pettmanna

a Institut National de la Santé et de la Recherche Médicale U.382, Developmental Biology Institute of Marseille (Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université de la Mediterranee, AP Marseille), Campus de Luminy-Case 907, 13288 Marseille Cedex 09, France
U.382, Campus de Luminy-Case 907, 13288 Marseille Cedex 09, France.(33) 4 91 26 97 57(33) 4 91 26 97 60

chris{at}ibdm.univ-mrs.fr

About 50% of spinal motoneurons undergo programmed cell death (PCD) after target contact, but little is known about how this process is initiated. Embryonic motoneurons coexpress the death receptor Fas and its ligand FasL at the stage at which PCD is about to begin. In the absence of trophic factors, many motoneurons die in culture within 2 d. Most (75%) of these were saved by Fas-Fc receptor body, which blocks interactions between Fas and FasL, or by the caspase-8 inhibitor tetrapeptide IETD. Therefore, activation of Fas by endogenous FasL underlies cell death induced by trophic deprivation. In the presence of neurotrophic factors, exogenous Fas activators such as soluble FasL or anti-Fas antibodies triggered PCD of 40–50% of purified motoneurons over the following 3–5 d; this treatment led to activation of caspase-3, and was blocked by IETD. Sensitivity to Fas activation is regulated: motoneurons cultured for 3 d with neurotrophic factors became completely resistant. Levels of Fas expressed by motoneurons varied little, but FasL was upregulated in the absence of neurotrophic factors. Motoneurons resistant to Fas activation expressed high levels of FLICE-inhibitory protein (FLIP), an endogenous inhibitor of caspase-8 activation. Our results suggest that Fas can act as a driving force for motoneuron PCD, and raise the possibility that active triggering of PCD may contribute to motoneuron loss during normal development and/or in pathological situations.

Key Words: motoneuron • Fas ligand • APO-1/CD95 • neuron killing • caspases



© 1999 The Rockefeller University Press

Abbreviations used in this paper: BDNF, brain-derived neurotrophic factor; CNTF, ciliary neurotrophic factor; CT-1, cardiotrophin-1; DAPI, 4',6-diamidino-2-phenylindole dihydrochloride; DIV, day(s) in vitro; FADD, Fas-associated death domain; Fas-Fc, recombinant human APO-1/Fas–Fc IgG; GDNF, glial cell line–derived neurotrophic factor; L, ligand; NTF, neurotrophic factors; PCD, programmed cell death; RT, reverse transcription; s, soluble.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents